Watch CLDI. Know when insiders buy.
One email the day a filing lands. Free.
CLDI
Calidi Biotherapeutics, Inc.
1.36
+0.01 +0.74%
USD · close Sep 9
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
0
FLAG · shorts 0
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $3.5MP/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME −$17.5MNET CASH $9M52W 1.27 – 26.72SEC XBRL · TTM TO Invalid Date
SEC filings, in plain English
| Filed | Form | What it is | Period | Document |
|---|---|---|---|---|
| Aug 19 | 4 | Insider transaction | Aug 17 | open on EDGAR ↗ |
| Aug 19 | 4 | Insider transaction | Aug 17 | open on EDGAR ↗ |
| Aug 19 | 4 | Insider transaction | Aug 17 | open on EDGAR ↗ |
| Aug 19 | 4 | Insider transaction | Aug 17 | open on EDGAR ↗ |
| Aug 19 | 4 | Insider transaction | Aug 17 | open on EDGAR ↗ |
| Aug 19 | 4 | Insider transaction | Aug 17 | open on EDGAR ↗ |
| Aug 19 | 4 | Insider transaction | Aug 17 | open on EDGAR ↗ |
| Aug 19 | 4 | Insider transaction | Aug 17 | open on EDGAR ↗ |
| Aug 14 | SCHEDULE 13G/A | — | open on EDGAR ↗ | |
| Aug 13 | 10-Q | Quarterly report | Jun 30 | open on EDGAR ↗ |
| Aug 13 | 8-K | Current report · Results announced, Regulation FD, Exhibits | Aug 13 | open on EDGAR ↗ |
| Jul 31 | 8-K | Current report · item 3.03, Bylaw or fiscal-year change, Exhibits | Jul 27 | open on EDGAR ↗ |
| Jul 16 | 8-K | Current report · Material agreement, Agreement terminated, New debt, Exhibits | Jul 10 | open on EDGAR ↗ |
| Jun 29 | 3 | Initial insider holding | Jun 17 | open on EDGAR ↗ |
| Jun 23 | 8-K | Current report · Officer or director change, Regulation FD, Other event, Exhibits | Jun 17 | open on EDGAR ↗ |
| Jun 18 | 8-K | Current report · Shareholder vote | Jun 12 | open on EDGAR ↗ |
| Jun 5 | DEFA14A | DEFA14A | — | open on EDGAR ↗ |
| May 29 | 8-K | Current report · Material agreement, Unregistered shares sold, Exhibits | May 28 | open on EDGAR ↗ |
| May 15 | SCHEDULE 13G | — | open on EDGAR ↗ | |
| May 14 | 10-Q | Quarterly report | Mar 31 | open on EDGAR ↗ |
| May 14 | 8-K | Current report · Results announced, Regulation FD, Exhibits | May 14 | open on EDGAR ↗ |
| May 8 | 8-K | Current report · Material agreement, Unregistered shares sold, Exhibits | May 6 | open on EDGAR ↗ |
| Apr 29 | DEFA14A | DEFA14A | — | open on EDGAR ↗ |
| Apr 29 | DEF 14A | Proxy statement | Apr 29 | open on EDGAR ↗ |
| Apr 17 | PRE 14A | PRE 14A | Apr 17 | open on EDGAR ↗ |
| Apr 2 | 8-K | Current report · Officer or director change, Other event, Exhibits | Mar 29 | open on EDGAR ↗ |
| Mar 31 | SCHEDULE 13D | — | open on EDGAR ↗ | |
| Mar 27 | 10-K | Annual report | Dec 31 | open on EDGAR ↗ |
| Mar 27 | 8-K | Current report · Results announced, Regulation FD, Exhibits | Mar 27 | open on EDGAR ↗ |
| Mar 11 | 8-K | Current report · Material agreement, Unregistered shares sold, Other event, Exhibits | Mar 5 | open on EDGAR ↗ |
| Mar 9 | SCHEDULE 13D | — | open on EDGAR ↗ | |
| Mar 9 | 424B5 | Prospectus supplement | — | open on EDGAR ↗ |
| Mar 6 | 424B5 | Prospectus supplement | — | open on EDGAR ↗ |
| Mar 5 | S-3MEF | S-3MEF | — | open on EDGAR ↗ |
| Feb 10 | SCHEDULE 13G/A | — | open on EDGAR ↗ | |
| Feb 10 | 8-K | Current report · Regulation FD, Exhibits | Feb 6 | open on EDGAR ↗ |
| Feb 4 | SCHEDULE 13G | — | open on EDGAR ↗ | |
| Jan 29 | 8-K | Current report · Results announced, Other event, Exhibits | Jan 28 | open on EDGAR ↗ |
| Dec 16 | 4 | Insider transaction | Dec 12 | open on EDGAR ↗ |
| Nov 13 | 10-Q | Quarterly report | Sep 30 | open on EDGAR ↗ |
Straight from the SEC's filing index, cached for six hours. Full history on EDGAR ↗